iSpecimen (ISPC)
(Real Time Quote from BATS)
$0.23 USD
-0.04 (-14.88%)
Updated May 10, 2024 03:48 PM ET
After-Market: $0.23 0.00 (0.00%) 4:06 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for iSpecimen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 10 | 10 | 11 | 8 | 4 |
Cost Of Goods | 5 | 5 | 5 | 4 | 2 |
Gross Profit | 5 | 6 | 6 | 5 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 16 | 16 | 12 | 7 | 6 |
Income After Depreciation & Amortization | -11 | -10 | -6 | -2 | -4 |
Non-Operating Income | 0 | 0 | -1 | 0 | 1 |
Interest Expense | 0 | 0 | 2 | 2 | 2 |
Pretax Income | -11 | -10 | -9 | -5 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -11 | -10 | -9 | -5 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -11 | -10 | -9 | -5 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -9 | -4 | -1 | -3 |
Depreciation & Amortization (Cash Flow) | 2 | 1 | 2 | 1 | 1 |
Income After Depreciation & Amortization | -11 | -10 | -6 | -2 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.04 | 8.84 | 4.29 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.23 | -1.16 | -2.09 | NA | NA |
Diluted Net EPS (GAAP) | -1.23 | -1.16 | -2.09 | -4.97 | NA |
Fiscal Year end for iSpecimen Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2.58 | 2.78 | 1.63 | 2.95 |
Cost Of Goods | NA | 1.43 | 1.39 | 0.85 | 1.15 |
Gross Profit | NA | 1.15 | 1.39 | 0.77 | 1.80 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.02 | 3.58 | 4.33 | 4.35 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.87 | -2.19 | -3.56 | -2.55 |
Non-Operating Income | NA | -0.20 | 0.09 | 0.08 | 0.11 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -3.07 | -2.11 | -3.48 | -2.43 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.07 | -2.11 | -3.48 | -2.43 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.07 | -2.11 | -3.48 | -2.43 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 9.04 | 9.07 | 9.03 | 8.98 |
Diluted EPS Before Non-Recurring Items | NA | -0.34 | -0.23 | -0.39 | -0.27 |
Diluted Net EPS (GAAP) | NA | -0.34 | -0.23 | -0.39 | -0.27 |